Clinical Trial Update: Japanese Phase I of GSK1605786 [Phase 1]

View source ↗

Summary

The Japanese Phase I trial of GSK1605786 for Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED